Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-10-02
2007-10-02
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S360000
Reexamination Certificate
active
10502261
ABSTRACT:
The present invention relates to piperidine derivatives of formula (I):whereinR represents halogen or C1-4alkyl;R1represents hydrogen or C1-4alkyl;R2represents hydrogen, C1-4alkyl;R3represents hydrogen, C1-4alkyl;R4represents trifluoromethyl, C1-4alkyl, C1-4alkoxy, trifluoromethoxy or halogen;R5represents hydrogen, C1-4alkyl, C3-7cycloalkyl, C(O)R6or S(O)2R6;R6represents C1-4alkyl or C3-7cycloalkyl;m is zero or an integer from 1 to 3;n is an integer from 1 to 3;p is an integer from 1 to 2;X and Y are independently C(O) or CH2;provided thati) X and Y are not both C(O) andii) when X and Y are both CH2and p is 1, R5is not hydrogen, C1-4alkyl or C(O)R6;and pharmaceutically acceptable salts and solvates thereof, the process for their preparation and their use in the treatment of conditions mediated by tachykinins.
REFERENCES:
patent: 4087424 (1978-05-01), Saikawa et al.
patent: 4110327 (1978-08-01), Saikawa et al.
patent: 4112090 (1978-09-01), Saikawa et al.
patent: 4219554 (1980-08-01), Saikawa et al.
patent: 4308387 (1981-12-01), Bjork et al.
patent: 4327097 (1982-04-01), Saikawa et al.
patent: 4379152 (1983-04-01), Saikawa et al.
patent: 4410522 (1983-10-01), Saikawa et al.
patent: 5028610 (1991-07-01), Hirai et al.
patent: 5109014 (1992-04-01), Jacobson et al.
patent: 5334606 (1994-08-01), MacLeod et al.
patent: 5348955 (1994-09-01), Greenlee et al.
patent: 5360820 (1994-11-01), Hagan et al.
patent: 5464788 (1995-11-01), Bock et al.
patent: 5538982 (1996-07-01), Hagan et al.
patent: 5563127 (1996-10-01), Amparo et al.
patent: 5576317 (1996-11-01), Gonsalves et al.
patent: 5696123 (1997-12-01), Dollinger et al.
patent: 5698538 (1997-12-01), Amparo et al.
patent: 5708006 (1998-01-01), Dollinger et al.
patent: 5710169 (1998-01-01), Russell et al.
patent: 5716942 (1998-02-01), Dorn et al.
patent: 5756504 (1998-05-01), Bock et al.
patent: 5814636 (1998-09-01), Katano et al.
patent: 5859015 (1999-01-01), Graham et al.
patent: 5883096 (1999-03-01), Lowe et al.
patent: 5935951 (1999-08-01), Ofner et al.
patent: 5952315 (1999-09-01), Baker et al.
patent: 5977104 (1999-11-01), Baker et al.
patent: 5985881 (1999-11-01), Dollinger et al.
patent: 5998444 (1999-12-01), Russell et al.
patent: 6037352 (2000-03-01), Lowe et al.
patent: 6057323 (2000-05-01), Zhang et al.
patent: 6090807 (2000-07-01), Hellendahl et al.
patent: 6114315 (2000-09-01), Baker et al.
patent: 6117855 (2000-09-01), Carlson et al.
patent: 6147083 (2000-11-01), Russell et al.
patent: 6191135 (2001-02-01), Dollinger et al.
patent: 6191139 (2001-02-01), Hagan et al.
patent: 6197772 (2001-03-01), Janssens et al.
patent: 6235732 (2001-05-01), Dollinger et al.
patent: 6288068 (2001-09-01), Lowe et al.
patent: 6319953 (2001-11-01), Carlson et al.
patent: RE37886 (2002-10-01), Janssens et al.
patent: 6521621 (2003-02-01), Janssens et al.
patent: 6642240 (2003-11-01), Alvaro et al.
patent: 2002/0103205 (2002-08-01), Lowe et al.
patent: 2519400 (1978-04-01), None
patent: 287734 (1987-10-01), None
patent: 293532 (1987-10-01), None
patent: 0655442 (1995-05-01), None
patent: 718287 (1995-12-01), None
patent: 0721941 (1996-07-01), None
patent: 1508062 (1975-04-01), None
patent: 57/118587 (1982-07-01), None
patent: WO92/16211 (1992-10-01), None
patent: WO95/00498 (1995-01-01), None
patent: WO95/25443 (1995-09-01), None
patent: WO96/02503 (1996-02-01), None
patent: WO96/03378 (1996-02-01), None
patent: WO96/10562 (1996-04-01), None
patent: WO96/14844 (1996-05-01), None
patent: WO96/20173 (1996-07-01), None
patent: WO97/16440 (1997-05-01), None
patent: WO97/32865 (1997-09-01), None
patent: WO97/36592 (1997-10-01), None
patent: WO97/36593 (1997-10-01), None
patent: WO97/36888 (1997-10-01), None
patent: WO97/36889 (1997-10-01), None
patent: WO98/01133 (1998-01-01), None
patent: WO98/20001 (1998-05-01), None
patent: WO98/57954 (1998-12-01), None
patent: WO99/09985 (1999-03-01), None
patent: WO99/26921 (1999-06-01), None
patent: WO 01/25219 (2001-04-01), None
patent: WO 02/00631 (2002-01-01), None
patent: WO 02/32867 (2002-04-01), None
patent: WO 02/055518 (2002-07-01), None
patent: WO 02/057233 (2002-07-01), None
patent: WO 03/099787 (2003-12-01), None
patent: WO 2004/033428 (2004-04-01), None
Vippagunta et al. Advanced Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Ohnmacht et al. Annual Reports in Medicinal Chemistry, vol. 33, p. 71-80 (1998).
Davis, David T., “Synthesis A. Biological Activity of a Series of Piperazin-2, 3-Biones,” Journal of Antibiotics, vol. XLII, No. 3, 1989, pp. 367-373.
Rupniak et al. “Differential inhibition of foot tapping and chromodacyorrhoea in gerbils by CNS penetrant and non-penetrant tachykinin NK, receptor antagonists.” European Journal of Pharmacology 265:179-183 (1994).
Megens, A., et al. J. Pharmacology and Experimental Therapeutics 302(2):696-709 (2002).
Challet, E., et al. Neuropharmacology 40(3):408-415 (2001).
Romerio, et al. Clinical Pharmacology and Therapeutics 66(5):522-527 (1999).
Pacher, P., et al. “Review of Cardiovascular Effects of Fluoxetine, A Selective Serotonine Rcuptake Inhibitor, Compared to Tricyclic Antidepressants.” Current Medicinal Chemistry, 5, 381-390, 1998.
Alvaro Giuseppe
Di Fabio Romano
Bernhardt Emily
Glaxo Group Limited
Morgan Lorie Ann
LandOfFree
Piperidine derivatives and their use as antagonists of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine derivatives and their use as antagonists of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivatives and their use as antagonists of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3901616